Question · asked by 1 review
RISPERIDONE vs ECT: Clinically important adverse effects other than central nervous system or EPS
- Population
- schizophrenia spectrum disorders with catatonic symptoms
- Intervention
- RISPERIDONE
- Comparison
- ECT
- Outcome
- Clinically important adverse effects other than central nervous system or EPS
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Risperidone vs electroconvulsive therapy (ECT) Clinically important adverse effects other than central nervous system or EPS · schizophrenia spectrum disorders with catatonic symptoms Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms (2022) · Cochrane Headline outcomes only | no estimate extracted | 1 study · 14 participants | GRADE not reported |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms 2022 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.